Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Authors
Keywords
Fatty liver, Fats, Type 2 diabetes, Ultrasound imaging, Glomerular filtration rate, Diabetes mellitus, Cholesterol, Insulin resistance
Journal
PLoS One
Volume 10, Issue 11, Pages e0142808
Publisher
Public Library of Science (PLoS)
Online
2015-11-14
DOI
10.1371/journal.pone.0142808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease—Is There a Link?
- (2014) L. Orlić et al. Gastroenterology Research and Practice
- Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease Proven by Transient Elastography
- (2013) Ivana Mikolasevic et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
- (2013) Masako Furukawa et al. TheScientificWorldJOURNAL
- Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes
- (2013) Wen-Shan Lv WORLD JOURNAL OF GASTROENTEROLOGY
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
- (2013) Melania Gaggini et al. Nutrients
- Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and Treatment
- (2012) Sandra Milic et al. DIGESTIVE DISEASES
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Non-alcoholic Fatty Liver Disease is an Independent Predictor for Macroangiopathy in Japanese Type 2 Diabetic Patients: A Cross-sectional Study
- (2012) Yuichiro Takeuchi et al. INTERNAL MEDICINE
- Non-Alcoholic Fatty Liver Disease Is not Related to the Incidence of Diabetic Nephropathy in Type 2 Diabetes
- (2012) Yu-Tao Zhan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The relationship between various measures of obesity and arterial stiffness in morbidly obese patients
- (2011) N Nordstrand et al. BMC Cardiovascular Disorders
- A Systematic Review of Propensity Score Methods in the Social Sciences
- (2011) Felix J. Thoemmes et al. MULTIVARIATE BEHAVIORAL RESEARCH
- Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method
- (2011) Ming-Feng Xia et al. Obesity
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis
- (2010) G. Targher et al. Clinical Journal of the American Society of Nephrology
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
- (2010) G. Targher et al. DIABETOLOGIA
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease
- (2009) Hongyun Lu et al. ARCHIVES OF MEDICAL RESEARCH
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
- (2009) C. H. KIM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started